Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alnylam Pharmaceuticals, Inc. (ALNY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alnylam Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1178670.
Total stock buying since 2014: $1,938,056,444.
Total stock sales since 2014: $464,736,445.
Total stock option exercises since 2014: $115,454,760.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 220,867 | $72,982,383 | 192,050 | $19,901,314 |
| 2024 | 0 | $0 | 180,137 | $41,538,738 | 151,030 | $11,355,349 |
| 2023 | 0 | $0 | 100,675 | $19,776,163 | 68,357 | $3,375,750 |
| 2022 | 0 | $0 | 121,519 | $26,219,683 | 121,196 | $6,550,509 |
| 2021 | 0 | $0 | 268,501 | $46,604,850 | 260,889 | $10,065,554 |
| 2020 | 0 | $0 | 627,192 | $86,811,603 | 608,710 | $21,285,941 |
| 2019 | 0 | $0 | 271,230 | $23,808,965 | 271,230 | $4,648,071 |
| 2018 | 0 | $0 | 336,545 | $45,286,903 | 389,257 | $12,575,964 |
| 2017 | 309,001 | $22,132,898 | 518,586 | $55,428,350 | 546,527 | $16,310,615 |
| 2016 | 234,930 | $15,449,889 | 119,619 | $7,505,502 | 183,397 | $3,818,292 |
| 2015 | 953,817 | $1,900,473,657 | 345,920 | $38,773,305 | 376,041 | $5,295,571 |
| 2014 | 0 | $0 | 0 | $0 | 17,000 | $271,830 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 61,068 | $27,120,619 | 42,698 | $5,308,450 |
| 2025-06 | 0 | $0 | 19,297 | $5,904,882 | 19,297 | $2,288,431 |
| 2025-05 | 0 | $0 | 42,890 | $12,755,751 | 42,890 | $5,228,299 |
| 2025-03 | 0 | $0 | 28,130 | $7,761,092 | 15,635 | $1,252,502 |
| 2025-02 | 0 | $0 | 5,640 | $1,357,569 | 11,404 | $0 |
| 2025-01 | 0 | $0 | 63,842 | $18,082,470 | 60,126 | $5,823,632 |
| 2024-12 | 0 | $0 | 1,752 | $440,838 | 0 | $0 |
| 2024-11 | 0 | $0 | 13,052 | $3,270,968 | 0 | $0 |
| 2024-08 | 0 | $0 | 72,423 | $19,598,365 | 71,123 | $6,850,274 |
| 2024-07 | 0 | $0 | 7,093 | $1,851,273 | 0 | $0 |
| 2024-06 | 0 | $0 | 47,262 | $10,569,631 | 32,450 | $2,500,175 |
| 2024-05 | 0 | $0 | 21,700 | $3,232,583 | 30,000 | $2,004,900 |
| 2024-02 | 0 | $0 | 16,855 | $2,575,080 | 17,457 | $0 |
| 2023-12 | 0 | $0 | 30,000 | $5,850,000 | 30,000 | $2,893,500 |
| 2023-08 | 0 | $0 | 25,649 | $4,770,470 | 22,477 | $0 |
| 2023-04 | 0 | $0 | 20,254 | $4,010,114 | 0 | $0 |
| 2023-03 | 0 | $0 | 18,072 | $3,614,400 | 5,000 | $482,250 |
| 2023-02 | 0 | $0 | 6,700 | $1,531,179 | 10,880 | $0 |
| 2022-11 | 0 | $0 | 67,500 | $14,850,000 | 67,500 | $4,798,911 |
| 2022-08 | 0 | $0 | 37,265 | $8,514,523 | 33,670 | $1,581,648 |
| 2022-07 | 0 | $0 | 1,754 | $263,100 | 0 | $0 |
| 2022-04 | 0 | $0 | 15,000 | $2,592,060 | 15,000 | $169,950 |
| 2022-02 | 0 | $0 | 0 | $0 | 5,026 | $0 |
| 2021-12 | 0 | $0 | 2,879 | $547,698 | 5,367 | $465,254 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-29 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 3,474 | 449.02 | 1,559,888 |
| 2025-08-19 | Garg Pushkal (EVP Chief R&D) | Sale | 1,455 | 458.88 | 667,670 |
| 2025-08-18 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 1,396 | 452.31 | 631,423 |
| 2025-08-18 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,396 | 452.31 | 631,423 |
| 2025-08-18 | Garg Pushkal (EVP Chief R&D) | Sale | 1,396 | 452.31 | 631,423 |
| 2025-08-18 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 2,274 | 452.31 | 1,028,550 |
| 2025-08-18 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 6,979 | 452.31 | 3,156,664 |
| 2025-08-18 | Bonney Michael W (Director) | Sale | 11,250 | 450.00 | 5,062,500 |
| 2025-08-18 | Bonney Michael W (Director) | Option Ex | 11,250 | 70.20 | 789,750 |
| 2025-08-14 | Ausiello Dennis A (Director) | Sale | 31,448 | 437.26 | 13,751,078 |
| 2025-08-14 | Ausiello Dennis A (Director) | Option Ex | 31,448 | 143.69 | 4,518,700 |
| 2025-06-02 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 19,297 | 306.00 | 5,904,882 |
| 2025-06-02 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 19,297 | 118.59 | 2,288,431 |
| 2025-05-30 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 31,640 | 305.00 | 9,650,200 |
| 2025-05-30 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 31,640 | 118.59 | 3,752,187 |
| 2025-05-15 | Bonney Michael W (Director) | Sale | 11,250 | 276.05 | 3,105,551 |
| 2025-05-15 | Bonney Michael W (Director) | Option Ex | 11,250 | 131.21 | 1,476,112 |
| 2025-03-24 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 5,445 | 300.00 | 1,633,500 |
| 2025-03-24 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Option Ex | 5,445 | 42.22 | 229,887 |
| 2025-03-24 | Pyott David E I (Director) | Sale | 7,440 | 299.00 | 2,224,560 |
| 2025-03-24 | Pyott David E I (Director) | Option Ex | 7,440 | 88.95 | 661,788 |
| 2025-03-21 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 4,321 | 285.00 | 1,231,485 |
| 2025-03-13 | Schulman Amy W (Director) | Option Ex | 2,750 | 131.21 | 360,827 |
| 2025-03-04 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 844 | 241.20 | 203,572 |
| 2025-03-04 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 808 | 241.12 | 194,823 |
| 2025-03-03 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 1,911 | 244.92 | 468,045 |
| 2025-03-03 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 471 | 244.82 | 115,311 |
| 2025-03-03 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 1,749 | 245.04 | 428,571 |
| 2025-03-03 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 1,264 | 245.33 | 310,093 |
| 2025-03-03 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 3,877 | 245.33 | 951,132 |
| 2025-02-28 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 496 | 240.70 | 119,389 |
| 2025-02-28 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 513 | 240.70 | 123,481 |
| 2025-02-28 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 935 | 240.70 | 225,058 |
| 2025-02-28 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 796 | 240.70 | 191,600 |
| 2025-02-28 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 2,900 | 240.70 | 698,041 |
| 2025-02-27 | Tanguler Tolga (EVP, Chief Commercial Officer) | Option Ex | 1,667 | .00 | 0 |
| 2025-02-27 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Option Ex | 1,908 | .00 | 0 |
| 2025-02-27 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Option Ex | 1,908 | .00 | 0 |
| 2025-02-27 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 5,921 | .00 | 0 |
| 2025-01-27 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 52,592 | 285.00 | 14,988,720 |
| 2025-01-27 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Option Ex | 48,876 | 88.95 | 4,347,520 |
| 2025-01-23 | Sharp Phillip A (Director) | Sale | 11,250 | 275.00 | 3,093,750 |
| 2025-01-23 | Sharp Phillip A (Director) | Option Ex | 11,250 | 131.21 | 1,476,112 |
| 2024-12-12 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 1,752 | 251.62 | 440,838 |
| 2024-11-27 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 1,531 | 252.59 | 386,710 |
| 2024-11-26 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 1,469 | 250.35 | 367,761 |
| 2024-11-26 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,469 | 250.35 | 367,761 |
| 2024-11-26 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 1,682 | 250.35 | 421,085 |
| 2024-11-26 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 1,682 | 250.35 | 421,085 |
| 2024-11-26 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 5,219 | 250.35 | 1,306,566 |
| 2024-08-20 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 15,000 | 280.00 | 4,200,000 |
| 2024-08-20 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 15,000 | 85.00 | 1,275,000 |
| 2024-08-12 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 22,025 | 271.83 | 5,986,989 |
| 2024-08-12 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Option Ex | 20,725 | 91.36 | 1,893,436 |
| 2024-08-06 | Ausiello Dennis A (Director) | Sale | 20,250 | 262.79 | 5,321,416 |
| 2024-08-06 | Ausiello Dennis A (Director) | Option Ex | 20,250 | 118.23 | 2,394,258 |
| 2024-08-01 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 15,148 | 270.00 | 4,089,960 |
| 2024-08-01 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 15,148 | 85.00 | 1,287,580 |
| 2024-07-11 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 7,093 | 261.00 | 1,851,273 |
| 2024-06-25 | Fitzgerald Kevin Joseph (CSO & EVP, Head of Research) | Sale | 1,198 | 229.42 | 274,846 |
| 2024-06-25 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,605 | 229.42 | 368,220 |
| 2024-06-25 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 2,103 | 229.42 | 482,472 |
| 2024-06-25 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 1,605 | 229.42 | 368,220 |
| 2024-06-25 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 8,301 | 229.42 | 1,904,423 |
| 2024-06-24 | Pyott David E I (Director) | Sale | 32,450 | 221.00 | 7,171,450 |
| 2024-06-24 | Pyott David E I (Director) | Option Ex | 32,450 | 77.05 | 2,500,175 |
| 2024-05-29 | Schulman Amy W (Director) | Sale | 21,700 | 148.97 | 3,232,583 |
| 2024-05-29 | Schulman Amy W (Director) | Option Ex | 30,000 | 66.83 | 2,004,900 |
| 2024-02-28 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 501 | 156.35 | 78,332 |
| 2024-02-28 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 574 | 156.35 | 89,746 |
| 2024-02-28 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 574 | 156.35 | 89,746 |
| 2024-02-28 | Franchini Indrani Lall (EVP, CLO & Secretary) | Sale | 329 | 156.35 | 51,439 |
| 2024-02-28 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 2,932 | 156.35 | 458,424 |
| 2024-02-27 | Tanguler Tolga (EVP, Chief Commercial Officer) | Option Ex | 1,667 | .00 | 0 |
| 2024-02-27 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Option Ex | 1,908 | .00 | 0 |
| 2024-02-27 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Option Ex | 1,908 | .00 | 0 |
| 2024-02-27 | Franchini Indrani Lall (EVP, CLO & Secretary) | Option Ex | 878 | .00 | 0 |
| 2024-02-27 | Greenstreet Yvonne (Chief Executive Officer) | Option Ex | 5,921 | .00 | 0 |
| 2024-02-16 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,009 | 148.26 | 149,591 |
| 2024-02-16 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 1,308 | 148.26 | 193,920 |
| 2024-02-16 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 1,007 | 148.26 | 149,294 |
| 2024-02-16 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 7,030 | 148.26 | 1,042,246 |
| 2024-02-02 | Franchini Indrani Lall (EVP, CLO & Secretary) | Sale | 1,591 | 171.18 | 272,342 |
| 2024-02-01 | Franchini Indrani Lall (EVP, CLO & Secretary) | Option Ex | 5,175 | .00 | 0 |
| 2023-12-27 | Bonney Michael W (Director) | Sale | 30,000 | 195.00 | 5,850,000 |
| 2023-12-27 | Bonney Michael W (Director) | Option Ex | 30,000 | 96.45 | 2,893,500 |
| 2023-08-07 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 4,166 | 184.52 | 768,697 |
| 2023-08-04 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 3,461 | 186.95 | 647,040 |
| 2023-08-04 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 3,460 | 186.95 | 646,853 |
| 2023-08-04 | Vaishnaw Akshay (President) | Sale | 4,057 | 186.95 | 758,464 |
| 2023-08-04 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 4,057 | 186.95 | 758,464 |
| 2023-08-03 | Bonney Michael W (Director) | Sale | 6,448 | 184.70 | 1,190,952 |
| 2023-08-02 | Bonney Michael W (Director) | Option Ex | 22,477 | .00 | 0 |
| 2023-04-28 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 2,455 | 198.55 | 487,440 |
| 2023-04-27 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,476 | 194.96 | 287,755 |
| 2023-04-27 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 1,839 | 194.96 | 358,524 |
| 2023-04-27 | Poulton Jeffrey V. (EVP, Chief Financial Officer) | Sale | 977 | 194.96 | 190,472 |
| 2023-04-27 | Vaishnaw Akshay (President) | Sale | 2,392 | 194.96 | 466,334 |
| 2023-04-27 | Greenstreet Yvonne (Chief Executive Officer) | Sale | 7,615 | 194.96 | 1,484,589 |
| 2023-04-06 | Franchini Indrani Lall (EVP, CLO & Secretary) | Sale | 3,500 | 210.00 | 735,000 |
| 2023-03-03 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Sale | 18,072 | 200.00 | 3,614,400 |
| 2023-03-03 | Garg Pushkal (CMO & EVP Dev & Med Affairs) | Option Ex | 5,000 | 96.45 | 482,250 |
| 2023-02-23 | Schulman Amy W (Director) | Option Ex | 136 | .00 | 0 |
| 2023-02-23 | Ausiello Dennis A (Director) | Option Ex | 136 | .00 | 0 |
| 2023-02-23 | Fanucci Marsha (Director) | Option Ex | 136 | .00 | 0 |
| 2023-02-23 | Hamburg Margaret A (Director) | Option Ex | 136 | .00 | 0 |
| 2023-02-23 | Pyott David E I (Director) | Option Ex | 136 | .00 | 0 |
| 2023-02-03 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 3,424 | 231.01 | 790,991 |
| 2023-02-02 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,601 | 225.94 | 361,734 |
| 2023-02-02 | Franchini Indrani Lall (EVP, CLO & Secretary) | Sale | 1,675 | 225.94 | 378,454 |
| 2023-02-01 | Tanguler Tolga (EVP, Chief Commercial Officer) | Option Ex | 5,025 | .00 | 0 |
| 2023-02-01 | Franchini Indrani Lall (EVP, CLO & Secretary) | Option Ex | 5,175 | .00 | 0 |
| 2022-11-21 | Ausiello Dennis A (Director) | Sale | 45,000 | 220.00 | 9,900,000 |
| 2022-11-21 | Ausiello Dennis A (Director) | Option Ex | 45,000 | 71.09 | 3,199,274 |
| 2022-08-15 | Sharp Phillip A (Director) | Sale | 33,670 | 229.93 | 7,741,810 |
| 2022-08-15 | Sharp Phillip A (Director) | Option Ex | 33,670 | 46.98 | 1,581,648 |
| 2022-08-05 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,841 | 219.65 | 404,373 |
| 2022-08-03 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,754 | 210.00 | 368,340 |
| 2022-07-05 | Tanguler Tolga (EVP, Chief Commercial Officer) | Sale | 1,754 | 150.00 | 263,100 |
| 2022-04-01 | Paul Steven M (Director) | Sale | 15,000 | 172.80 | 2,592,060 |
| 2022-04-01 | Paul Steven M (Director) | Option Ex | 15,000 | 11.33 | 169,950 |
| 2022-02-01 | Tanguler Tolga (EVP, Chief Commercial Officer) | Option Ex | 5,026 | .00 | 0 |
| 2021-12-23 | Vaishnaw Akshay (President, R&D) | Sale | 2,879 | 190.24 | 547,698 |
| 2021-12-10 | Maraganore John (Chief Executive Officer) | Option Ex | 5,367 | 86.69 | 465,254 |
| 2021-11-12 | Maraganore John (Chief Executive Officer) | Sale | 33,978 | 172.30 | 5,854,545 |
| 2021-11-12 | Maraganore John (Chief Executive Officer) | Option Ex | 33,978 | 7.10 | 241,243 |
| 2021-08-13 | Maraganore John (Chief Executive Officer) | Sale | 33,979 | 199.85 | 6,790,771 |
| 2021-08-13 | Maraganore John (Chief Executive Officer) | Option Ex | 33,979 | 7.10 | 241,250 |
| 2021-08-09 | Vaishnaw Akshay (President, R&D) | Sale | 10,834 | 200.00 | 2,166,800 |
| 2021-08-09 | Vaishnaw Akshay (President, R&D) | Option Ex | 10,834 | 63.00 | 682,542 |
| 2021-08-06 | Greenstreet Yvonne (President & COO) | Sale | 53,064 | 199.00 | 10,559,736 |
| 2021-08-06 | Greenstreet Yvonne (President & COO) | Option Ex | 53,064 | 77.10 | 4,091,234 |
| 2021-08-05 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 10,000 | 188.95 | 1,889,500 |
| 2021-08-05 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 10,000 | 88.95 | 889,500 |
| 2021-07-12 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 6,812 | 178.97 | 1,219,177 |
| 2021-07-12 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 6,812 | 86.97 | 592,473 |
| 2021-06-18 | Vaishnaw Akshay (President, R&D) | Sale | 14,708 | 175.00 | 2,573,900 |
| 2021-06-18 | Vaishnaw Akshay (President, R&D) | Option Ex | 11,804 | 52.61 | 621,008 |
| 2021-05-13 | Maraganore John (Chief Executive Officer) | Sale | 33,979 | 131.34 | 4,462,835 |
| 2021-05-13 | Maraganore John (Chief Executive Officer) | Option Ex | 33,979 | 7.10 | 241,250 |
| 2021-04-21 | Vaishnaw Akshay (President, R&D) | Sale | 2,732 | 137.08 | 374,510 |
| 2021-04-19 | Vaishnaw Akshay (President, R&D) | Sale | 3,706 | 138.25 | 512,373 |
| 2021-02-25 | Maraganore John (Chief Executive Officer) | Sale | 33,979 | 149.18 | 5,069,089 |
| 2021-02-25 | Maraganore John (Chief Executive Officer) | Option Ex | 33,979 | 7.10 | 241,250 |
| 2021-01-13 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 9,027 | 171.00 | 1,543,617 |
| 2021-01-13 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 9,027 | 81.20 | 732,992 |
| 2021-01-12 | Keating Laurie (EVP, Chief Legal Officer) | Sale | 14,941 | 162.00 | 2,420,442 |
| 2021-01-12 | Keating Laurie (EVP, Chief Legal Officer) | Option Ex | 14,941 | 59.81 | 893,621 |
| 2021-01-12 | Greenstreet Yvonne (President & COO) | Sale | 3,125 | 161.00 | 503,125 |
| 2021-01-12 | Greenstreet Yvonne (President & COO) | Option Ex | 3,125 | 42.22 | 131,937 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALNY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alnylam Pharmaceuticals, Inc. (symbol ALNY, CIK number 1178670) see the Securities and Exchange Commission (SEC) website.